Quest Diagnostics DGX Free cash flow yield
Free cash flow yield at other companies
Other financials
Where this comes from
Calculated from Quest Diagnostics’s reported figures.
Based on trailing twelve months.
The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →
Ask your AI about Quest Diagnostics's free cash flow yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Quest Diagnostics's free cash flow yield?
- Quest Diagnostics (DGX) reported free cash flow yield of 6.2% in Q1 2026.
- How has Quest Diagnostics's free cash flow yield changed year-over-year?
- Quest Diagnostics's free cash flow yield increased by 9.5% year-over-year, from 5.6% to 6.2%.
- What is the long-term trend for Quest Diagnostics's free cash flow yield?
- Over 4 years (2021 to 2025), Quest Diagnostics's free cash flow yield has grown at a -13.7% compound annual growth rate (CAGR), from 45.7% to 25.3%.
- What does free cash flow yield mean?
- The spendable cash the business throws off each year as a percentage of its market price.
- How do you interpret free cash flow yield?
- Higher yield can mean better value — you pay less for each dollar of cash generated. A useful sanity check against earnings-based multiples, which non-cash items can distort.
- How does free cash flow yield compare across companies?
- Comparable across cash-generative companies; less meaningful for firms in heavy-investment phases with temporarily negative FCF.